The headline on this post comes from the last sentence in this TimesOnline story,
Filed under: Emerging Markets Labeling | Leave a Comment »
The headline on this post comes from the last sentence in this TimesOnline story,
Filed under: Emerging Markets Labeling | Leave a Comment »
Meeting last week at the Massachusetts Institute of Technology (MIT), the GS1 MobileCom Work Group entertained the advice and feeedback of Alexander Muse.
Filed under: GS1 | Leave a Comment »
Here’s another strong piece of evidence that established, market-leading companies in developed countriesare learning that emerging markets may hold the key to their continued global leadership. This time, it’s about the airline industry, two key players in Boeing and Airbus, and China.
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Here’s an unusual, but very timely, application of GS1 standards:
Filed under: GS1, GS1 Adoption, Track & Trace | Leave a Comment »
This comes from a long news release, but the important message is pretty straightforward: GS1 Canada and GHX have agreed to form a strategic alliance to create a global standards-based product registry for healthcare products.
Filed under: C-Level Issues, GS1, GS1 Adoption, Global Standards, Hospital, Patient safety | Leave a Comment »
GS1 has published a new Call to Action for the purpose of forming a Work Group to study the issue of managing multiple bar codes on a single end user package.
Filed under: GS1 | Leave a Comment »
Conceptually, it is hard to argue against a global product marking standard understood by all. But when it comes down to the level of practical implementation, there can be significant implications. In this posting by Tom Karst on The Packer site, an anonymous retailer’s comments about GTIN adoption raise some serious concerns.
Filed under: C-Level Issues, GS1, GS1 Adoption, Track & Trace | Leave a Comment »
The Seeking Alpha site has a great, brief, 10-company update on pharmaceutical, biotechnology and medical devices companies launching initiatives, or experiencing improved profitability, in emerging markets.
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
If and when you first read this InfoWorld aticle by Carol Ko entitled ‘HK launches measures against counterfeit products,’ you may ask
Filed under: C-Level Issues, GS1, GS1 Adoption, Global Standards, Patient safety, Track & Trace | 1 Comment »
This just in… This IBM press release out of Armonk, NY, this morning confirms that GS1 UK has engaged IBM to help find and fix supply chain data gaps
Filed under: GS1, GS1 Adoption, Track & Trace | Leave a Comment »
Reading this piece in MoneyWeek by Editor John Stepek is like watching dominoes fall. Entitled “Emerging markets will be the winners from this crisis,” it sounds like a positive story, doesn’t it? And it is, actually, but only if you’re able to set aside the projected sequence of events that will happen in the developed [...]
Filed under: GS1 | Leave a Comment »
Everybody has their reasons for embracing, or shunning, an emerging market strategy. But if you want to know what ‘the world’s leading drug maker’ is thinking about emerging markets, and their reasons for thinking it, you’ll check out this very brief bulletin today in FinancierWorldwide featuring Jean-Michel Halfon, who runs Pfizer’s emerging market unit.
Filed under: Emerging Markets Labeling, Pharma | Leave a Comment »